Stay updated on Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.

Latest updates to the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page
- Check10 days agoChange DetectedA site-wide NIH banner about the transition from “Artificial Intelligence” to “Super Intelligence” appeared, and the site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.9%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check45 days agoChange DetectedThe history now shows a new revision entry for v3.7.0 as the latest update. The older revision label v3.6.6 has been removed from the visible history.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry v3.6.6 was added to the study's Record History. The previous revision v3.6.5 was removed.SummaryDifference0.1%

- Check80 days agoChange DetectedThe Record History adds a new revision entry (v3.6.5) and removes the prior revision (v3.6.4). This reflects a site version update in the history log rather than changes to the study content.SummaryDifference0.1%

- Check94 days agoChange DetectedA new revision entry v3.6.4 was added to the study’s record history, and the previous revision v3.6.3 was removed from the current history view.SummaryDifference0.1%

Stay in the know with updates to Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.